A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

PHASE2CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 7, 2012

Primary Completion Date

February 8, 2017

Study Completion Date

February 8, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

Crenezumab

Participants will receive intravenous infusion of crenezumab every 4 weeks for 144 weeks.

Trial Locations (86)

2006

Complejo Hospitalario Universitario de Albacete, Albacete

10032

Columbia University Medical Center, New York

11030

Litwin Zucker Research Ctr.; Feinstein Inst. Med. Rsch., Manhasset

12203

Univ Berlin; Klin fur Psychi & Psycho Charite, Berlin

12210

Empire Neurology, PC, Latham

14627

University of Rochester Medical Center; Monroe Community Hospital, Rochester

14642

Investigational Drug Service; Univ of Rochester Medical Ctr, Rochester

19046

The Clinical Trial Center, LLC, Jenkintown

20009

Policlinica Guipuzcoa, Donostia / San Sebastian

28006

Clinica Ruber, 4 planta; Servicio de Neurologia, Madrid

29425

Medical Uni of South Carolina, North Charleston

30033

Dekalb Neurology Associates, Decatur

32806

Bioclinica Research, Orlando

33137

Miami Jewish Health Systems; Clinical Research, Miami

33407

Premiere Research Institute, West Palm Beach

33431

Florida Atlantic University; College of Medicine, Boca Raton

33445

Brain Matters Research, Inc., Delray Beach

33609

Axiom Clinical Research of Florida, Tampa

34105

Collier Neurologic Specialists, Naples

34601

Meridien Research, Brooksville

39401

Hattiesburg Clinic, Hattiesburg

44093

Hopital Nord Laennec, Nantes

46202

Indiana Univ School of Med, Indianapolis

48903

Hospital de Cruces; Servicio de Neurologia, Barakaldo

54035

Hopital Central; Neurologie, Nancy

60007

Alexian Brothers Neurosci Inst, Elk Grove Village

60612

Rush Alzheimer's Disease Cntr., Chicago

63132

Millennium Psychiatric Associates, LLC, St Louis

67091

Hôpital Civil de Strasbourg, Strasbourg

68159

Zentralinstitut fuer Seelische Gesundheit, Mannheim

69677

Hopital neurologique Pierre Wertheimer - CHU Lyon; Neurologie, Bron

70114

Louisiana Research Associates, New Orleans

72076

Universitätsklinik Tübingen; Psychiatrie und Psychotherapie, Tübingen

76031

CHU de Rouen Hopital; Service de Neurologie, Rouen

77030

Alzheimers Disease & Memory Disorders Center; Department of Neurology Baylor College of Medicine, Houston

81377

Ludwig-Maximilians-Univ., München

81675

Klinikum rechts der Isar der Technischen Universität München, München

85006

Banner Alzheimer's Institute, Phoenix

85259

Mayo Clinic, Scottsdale

85351

Banner Sun Health Research Insitute, Sun City

87042

CHU de Limoges Hopital Dupuytren; Service de Medecine Geriatrique, Limoges

89106

Cleveland Clinic Lou Ruvo; Center for Brain Research, Las Vegas

89312

Bezirkskrankenhaus Günzburg, Günzburg

90033

USC School of Medicine, Los Angeles

90095

University of California Los Angeles (UCLA), Los Angeles

91316

Pharmacology Research Inst, Encino

92037

Univ of CA San Diego; Neurosciences Comp.Alzheimer's, La Jolla

92103

Pacific Research Network - PRN, San Diego

92660

Pharmacology Research Inst, Newport Beach

93030

Pacific Neuroscience Med Grp, Oxnard

93720

Margolin Brain Institute, Fresno

94117

Uni of California San Francisco, San Francisco

94304

Stanford Univ Medical Center, Palo Alto

95403

Redwood Regional Medical Group, Santa Rosa

95817

University of California Davis Medical System, Sacramento

97210

Summit Research Network Inc., Portland

06511

Yale University, New Haven

07724

Memory Enhancement Center of America, Inc., Eatontown

07856

NeuroCognitive Institute, Mount Arlington

27607-6520

Raleigh Neurology Associates, Raleigh

02914

Rhode Island Mood & Memory Research Institute, East Providence

02906

Butler Hospital, Providence

05201

Clinical Neuroscience Research Associates, Inc., Bennington

V1Y 3G8

The Med Arts Health Rsrch Grp, Kelowna

V6T 2B5

University of British Columbia Hospital; Division of Neurology, Vancouver

B3H 2E1

Capitol District Health Authority, Halilfax

L7M 4Y1

Jbn Medical Diagnostic Services Inc., Burlington

K7L 2V7

Hotel Dieu Hospital, Kingston

N6C 5J1

St. Joseph's HC-Parkwood Hosp, London

K1N 5C8

Bruyere Continuing Care, Ottawa

K9H 2P4

Kawartha Centre - Redefining Healthy Aging, Peterborough

M3B 2S7

Toronto Memory Program (Neurology Research Inc.), Toronto

J4V 2J2

Clinique Neuro Rive-Sud, Greenfield Park

H1T 2M4

Hôpital Maisonneuve-Rosemont/Polyclinique;Recherche Clinique, Montreal

G1J 1Z4

CHAUQ Hopital Enfant-Jesus, Québec

H4H 1R3

McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric, Verdun

08034

Fundació ACE, BArcelon

08195

Hospital General de Catalunya, San Cugat Del Valles

BA1 3NG

The Rice Centre; Royal United Hospital, Bath

TW8 8DS

West London Research Unit; Brentford Lodge, Brentford

BN2 5BE

Royal Sussex County Hospital, CIRU Level 5, Brighton

G20 0XA

Glasgow Memory Clinic, Glasgow

WC1N 3BG

The National Hospital for Neurology & Neurosurgery; Dementia Research Center, London, GT LON

SO16 6YD

Southampton General Hospital; Pharmacy, Southampton

SO30 3JB

Moorgreen Hospital; Memory Assessment & Rsch Ctr, Southampton

SN3 6BW

Great Western Hosp.; Kingshill Research Ctr, Swindon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY